Navigation Links Added New Report on Levocarnitine (CAS 541-15-1) Market to Its Catalogue

London, UK (PRWEB) September 27, 2013 announces that a new research report on the levocarnitine (CAS 541-15-1) market created by BAC Reports is available in its catalogue.

The newly published report, “Levocarnitine (CAS 541-15-1) Market Research Report 2013,” draws up an elaborate picture of the levocarnitine market. It presents a comprehensive product profile, which contains levocarnitine’s description, a review of its composition and ingredients, information on the main health risks, insight into toxicological and ecological effects of the chemical, and a variety of handling, storage and transportation requirements. The research study presents an overview of levocarnitine’s properties, discusses the major production methods and details major applications of the product.

The study presents in-depth insights into the levocarnitine market globally and across major regions, and offers detailed profiles of the leading and niche manufacturers and traders active in the levocarnitine marketplace on a global and regional scale. Additionally, the report provides a snapshot of the key consumers of levocarnitine across key end-use sectors, besides looking into pricing issues by region.

Report Details:

Title: Levocarnitine (CAS 541-15-1) Market Research Report 2013
Published: September, 2013
Price: US$ 2,650.00

The geographical markets covered in the report are as follows: Asia, Europe, and North America.

The companies profiled in the research study include: Acros Organics B.V.B.A., Merck KGaA, Lonza A.G., Abtonsmart Chemicals Co., Ltd., Mira Biotechnology Co., Ltd., Nanchang Polis Bio-Tech Co., Ltd., Sunrise Chemical Co., Ltd, Suntran Industrial Group Ltd., Finetech Industry Limited, Biocon, Watanabe Chemical Industries International, Hubei Maxpharm Industries Co., Ltd., Tokyo Chemical Industry Co., Ltd., Toronto Research Chemicals Inc., Wonda Science Inc., Advanced ChemTech, and EMD Millipore Corporation, amid many others.

Reasons to Buy:

  •     The report is a source of critical information on the global levocarnitine market.
  •     Comprehensive product profile enriches one’s knowledge of levocarnitine, enabling to take informed business decisions.
  •     Insights into the levocarnitine market and data on the regional prices assist in identifying the most promising markets as well as in planning effective business strategies.
  •     Examination of the competitive environment helps to evaluate the level of competition within the market and thereby gain a competitive advantage over the rivals.
  •     Detailed profiles of the companies operating in the levocarnitine market contain all the information required to find prospective business partners.

More CAS chemicals reports by the publisher can be found at BAC Reports page.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Global Cancer Diagnostics Market to Witness Robust Growth, According to VPG Report Published at
2. Polyhydroxyalkanoate Demand to Grow Significantly in Future, According to M&M Study Published at
3. Added New Report on Hydroxyethyl Starch (CAS 9005-27-0) Market to Its Catalogue
4. Added New Report on Povidone Iodine (CAS 25655-41-8) Market to Its Catalogue
5. Added New Report on Mannitol (CAS 87-78-5) Market to Its Catalogue
6. Added New Report on 1-Ethynyl-1-cyclohexanol (CAS 78-27-3) Market to Its Catalogue
7. Aloe Vera Market Reviewed in Topical Research Study by BAC Reports Published at
8. Added New Report on 1,5-Diaminopentane (1,5-Pentanediamine) (CAS 462-94-2) Market to Its Catalogue
9. Added New Report on Ceramide (CAS 100403-19-8) Market to Its Catalogue
10. Added New Report on 1,2-Diaminopropane (CAS 78-90-0) Market to Its Catalogue
11. Added New Report on Hydroquinone (CAS 123-31-9) Market to Its Catalogue
Post Your Comments:
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris from 17 th ... Paris from 17 th until 19 th ... leader, has invented the first combined scanner in the world ... scanning surface. Until now two different scanners were required: one ... both on the same surface. This innovation is an ...
(Date:11/16/2015)... JOSE, Calif. , Nov 16, 2015 /PRNewswire/ ... developer of human interface solutions, today announced expansion ... Synaptics TouchView ™ touch controller and display ... architectural revolution of smartphones. These new TDDI products ... include TD4100 (HD resolution), TD4302 (WQHD resolution), and ...
(Date:11/11/2015)... MINNETONKA, Minn. , Nov. 11, 2015   MedNet ... the entire spectrum of clinical research, is pleased to announce ... Partnerships in Clinical Trials (PCT) event, to be held ... will be able to view live demonstrations of ... platform, and learn how iMedNet has been able ...
Breaking Biology News(10 mins):